Obesity impairs resistance to Leishmania major infection in C57BL/6 mice.
Journal
PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488
Informations de publication
Date de publication:
01 2020
01 2020
Historique:
received:
05
06
2018
accepted:
28
10
2019
entrez:
11
1
2020
pubmed:
11
1
2020
medline:
14
4
2020
Statut:
epublish
Résumé
An association between increased susceptibility to infectious diseases and obesity has been described as a result of impaired immunity in obese individuals. It is not clear whether a similar linkage can be drawn between obesity and parasitic diseases. To evaluate the effect of obesity in the immune response to cutaneous Leishmania major infection, we studied the ability of C57BL/6 mice fed a hypercaloric diet (HSB) to control leishmaniasis. Mice with diet-induced obesity presented thicker lesions with higher parasite burden and a more intense inflammatory infiltrate in the infected ear after infection with L. major. There was no difference between control and obese mice in IFN-gamma or IL-4 production by auricular draining lymph node cells, but obese mice produced higher levels of IgG1 and IL-17. Peritoneal macrophages from obese mice were less efficient to kill L. major when infected in vitro than macrophages from control mice. In vitro stimulation of macrophages with IL-17 decreased their capacity to kill the parasite. Moreover, macrophages from obese mice presented higher arginase activity. To confirm the role of IL-17 in the context of obesity and infection, we studied lesion development in obese IL-17R-/- mice infected with L. major and found no difference in skin lesions and the leukocyte accumulation in the draining lymph node is redcuced in knockout mice compared between obese and lean animals. Our results indicate that diet-induced obesity impairs resistance to L. major in C57BL/6 mice and that IL-17 is involved in lesion development.
Identifiants
pubmed: 31923234
doi: 10.1371/journal.pntd.0006596
pii: PNTD-D-18-00813
pmc: PMC6953764
doi:
Substances chimiques
Interleukin-17
0
Interferon-gamma
82115-62-6
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0006596Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Nat Med. 2009 Aug;15(8):930-9
pubmed: 19633656
Nat Immunol. 2007 Sep;8(9):950-7
pubmed: 17676044
J Immunol. 2009 Mar 1;182(5):3039-46
pubmed: 19234200
J Exp Med. 1998 Jul 6;188(1):217-22
pubmed: 9653099
Immunol Allergy Clin North Am. 2014 Nov;34(4):753-65
pubmed: 25282288
J Immunol. 1996 Jul 15;157(2):827-35
pubmed: 8752935
Cell Rep. 2015 Aug 11;12(6):1042-55
pubmed: 26235623
J Immunol. 1989 Jul 15;143(2):617-22
pubmed: 2525590
J Exp Med. 2005 Mar 7;201(5):747-54
pubmed: 15753208
Int J Obes (Lond). 2013 Nov;37(11):1510-3
pubmed: 23439322
Trends Mol Med. 2013 Aug;19(8):487-500
pubmed: 23746697
PLoS One. 2014 Sep 25;9(9):e108494
pubmed: 25254662
Obes Rev. 2015 Dec;16(12):1017-29
pubmed: 26354800
J Immunol. 2000 Jul 15;165(2):969-77
pubmed: 10878373
Nat Rev Immunol. 2002 Nov;2(11):845-58
pubmed: 12415308
Front Immunol. 2014 Aug 11;5:379
pubmed: 25157251
J Nutr. 2010 Sep;140(9):1691-7
pubmed: 20592105
Nature. 2006 Dec 14;444(7121):860-7
pubmed: 17167474
J Infect Dis. 2010 Oct 1;202(7):1104-13
pubmed: 20726767
Obesity (Silver Spring). 2013 Nov;21(11):2377-86
pubmed: 23512822
Front Public Health. 2013 Dec 25;1:73
pubmed: 24400300
Infect Immun. 1993 Jul;61(7):2952-9
pubmed: 8514400
J Nutr. 1993 Nov;123(11):1939-51
pubmed: 8229312
Malar J. 2008 May 19;7:81
pubmed: 18489748
J Immunol Methods. 1994 Sep 14;174(1-2):231-5
pubmed: 8083527
Lancet Infect Dis. 2011 Jan;11(1):14-5
pubmed: 21183146
J Clin Invest. 2007 Jan;117(1):175-84
pubmed: 17200717
Parasite Immunol. 2014 Jan;36(1):13-31
pubmed: 24102495
J Infect Dis. 2012 Mar 1;205(5):830-40
pubmed: 22293433
Anal Biochem. 1982 Oct;126(1):131-8
pubmed: 7181105
Parasitology. 2016 Oct;143(12):1647-55
pubmed: 27440305
Nat Med. 2009 Aug;15(8):914-20
pubmed: 19633658
Science. 1996 Feb 16;271(5251):987-90
pubmed: 8584936
Nat Rev Immunol. 2008 Dec;8(12):923-34
pubmed: 19029988
Cytokine. 2015 Dec;76(2):545-548
pubmed: 26239414
J Innate Immun. 2015;7(4):392-404
pubmed: 25720383
J Immunol. 2007 Jan 15;178(2):1077-85
pubmed: 17202371
Inflamm Res. 2016 Feb;65(2):169-78
pubmed: 26650032
Infect Immun. 2009 Mar;77(3):1008-14
pubmed: 19103772
PLoS One. 2010 Jan 25;5(1):e8660
pubmed: 20107494
PLoS Negl Trop Dis. 2014 Oct 02;8(10):e3118
pubmed: 25275627
Scand J Clin Lab Invest. 2015 Nov;75(7):595-601
pubmed: 26216210
Int J Clin Exp Med. 2015 Sep 15;8(9):15403-12
pubmed: 26629029
Infect Immun. 2002 Aug;70(8):3994-4001
pubmed: 12117904
Diabetologia. 2016 May;59(5):879-94
pubmed: 26940592
J Immunol. 1991 Nov 1;147(9):3149-55
pubmed: 1833466
Science. 1993 Jan 1;259(5091):87-91
pubmed: 7678183
Microbiol Immunol. 2007;51(12):1139-47
pubmed: 18094532
J Immunol. 2010 Aug 1;185(3):1836-45
pubmed: 20581149
Immunology. 2019 Apr;156(4):339-355
pubmed: 30472727
PLoS Pathog. 2013 Mar;9(3):e1003243
pubmed: 23555256
Front Immunol. 2012 Jun 04;3:129
pubmed: 22675324
Science. 2011 Apr 1;332(6025):65-8
pubmed: 21350122
J Biol Chem. 2004 May 28;279(22):23668-78
pubmed: 15023992
J Biol Chem. 1951 Nov;193(1):265-75
pubmed: 14907713
Trends Parasitol. 2017 Apr;33(4):276-284
pubmed: 28007406